Trident Texofab Ltd

Trident Texofab Ltd’s stock price declined to a fresh 52-week low of Rs.34.59 on 09 June 2026, marking a significant downturn amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices.

For the sixth consecutive session, Trident Texofab Ltd has closed lower, culminating in a fresh 52-week low of Rs 35.55 on 8 Jun 2026. This marks a steep 15.5% decline over this losing streak and a staggering 82.57% drop over the past year, sharply underperforming the Sensex's 10.46% fall in the same period.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite this improvement, the company’s stock continues to face significant headwinds, reflected in its recent price decline and a strong sell mojo grade. This article analyses the evolving valuation metrics, compares them with peers and historical benchmarks, and assesses the implications for investors navigating a challenging market environment.

Trident Texofab Ltd., a Surat-based garments and apparels manufacturer, reported a devastating fourth quarter for FY26, posting a net loss of ₹2.01 crores compared to a profit of ₹0.51 crores in the same quarter last year. The micro-cap company with a market capitalisation of ₹65.00 crores has seen its stock price collapse by 79.14% over the past year, with shares trading at ₹41.70 as of June 1, 2026, down 4.66% on the day following the results announcement.

Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, has reported a significant deterioration in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to negative, with key metrics such as net sales, profit after tax, and operating margins showing marked declines compared to previous quarters and historical averages.

Trident Texofab Ltd’s investment rating has been upgraded from Strong Sell to Sell as of 18 May 2026, reflecting a nuanced shift in its technical outlook amid persistent fundamental challenges. While the company’s financial performance remains subdued, improvements in technical indicators have prompted a reassessment of its near-term prospects, signalling a cautiously less bearish stance for investors.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Feb 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 03 May 2026, providing investors with the latest perspective on the company’s position.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Feb 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 April 2026, providing investors with the latest insights into its performance and outlook.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 27 March 2026, providing investors with the latest comprehensive analysis.

Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, has touched a new 52-week low of Rs.38.57 today, marking a significant milestone in its ongoing decline. The stock has been on a downward trajectory for 21 consecutive trading sessions, culminating in a cumulative loss of 65.84% over this period.

Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, touched a fresh 52-week low of Rs.40.6 today, marking a significant milestone in its ongoing decline. The stock has now recorded a consecutive 21-day losing streak, reflecting a cumulative fall of 65.82% over this period, underscoring persistent pressures on the company’s market valuation.

Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, touched a fresh 52-week low of Rs.42.73 on 17 Mar 2026, marking a significant decline amid sustained downward momentum. The stock has now recorded a 21-day consecutive fall, losing 65.83% in returns over this period, reflecting ongoing pressures in its market performance and fundamentals.

Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, has touched a new 52-week low of Rs.44.97 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and market sentiment.